Insider Purchase: Director at $MSDL Buys 5,700 Shares

Kevin Shannon, a director at $MSDL, bought 5,700 shares of the company on 06-06-2025 for an estimated $110,722. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 5,700 shares of this class of $MSDL stock.

$MSDL Insider Trading Activity

$MSDL insiders have traded $MSDL stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MSDL stock by insiders over the last 6 months:

• KEVIN SHANNON has made 3 purchases buying 10,000 shares for an estimated $194,293 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MSDL Hedge Fund Activity

We have seen 78 institutional investors add shares of $MSDL stock to their portfolio, and 28 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY added 2,247,485 shares (+17.1%) to their portfolio in Q1 2025, for an estimated $44,859,800
• CLIFFWATER LLC removed 1,203,819 shares (-83.3%) from their portfolio in Q1 2025, for an estimated $24,028,227
• GENERALI ASSET MANAGEMENT SPA SGR added 881,578 shares (+inf%) to their portfolio in Q1 2025, for an estimated $17,596,296
• UBS GROUP AG added 463,504 shares (+287.4%) to their portfolio in Q1 2025, for an estimated $9,251,539
• RENAISSANCE TECHNOLOGIES LLC removed 337,936 shares (-95.8%) from their portfolio in Q1 2025, for an estimated $6,745,202
• WELLS FARGO & COMPANY/MN added 269,954 shares (+920.8%) to their portfolio in Q1 2025, for an estimated $5,388,281
• TWO SIGMA INVESTMENTS, LP added 239,299 shares (+inf%) to their portfolio in Q1 2025, for an estimated $4,776,408

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.